Research and Development

Asubio is committed to improving clinical outcomes and quality of life of people suffering from devastating CNS, cardiovascular, immunological and inflammatory conditions. Taking entities discovered through chemical synthesis, biotechnology and peptide chemistry which originate in the company’s discovery laboratories in Japan, our scientists combine individual initiative with scientific knowledge, expertise and teamwork to investigate new and better treatment alternatives for patients.

Matching unmet medical need with advances in clinical development is a core competency at Asubio, and is at the center of our work. Our teams maintain close cooperation with health care professionals in their chosen fields of study to improve our knowledge of disease processes. We apply that knowledge and our understanding of rational clinical trial design to our development efforts, paying special attention to areas of medicine where limited options exist for patient care.

For more information about the development pipeline of Asubio, please click here.